NCT06512883

A Trial to Investigate Benralizumab in Children With Eosinophilic Diseases

RecruitingPHASE3INTERVENTIONAL

Trial Details

Start: 2025-04-17Est. Completion: 2028-02-20

Enrollment target: 14 participants

Locations

Contact

AstraZeneca Clinical Study Information Center

Eosinophilic Granulomatosis With Polyangiitis

This study aims to investigate the efficacy and safety of depemokimab compared with mepolizumab in adults with relapsing…

Denver, United StatesEst. completion Sep 29, 2026

GPAVasculitisMicroscopic Polyangiitis (MPA)Churg-Strauss Syndrome (CSS)

The current state of knowledge on ANCA-associated vasculitis (AAV) indicates that it is a group of autoimmune diseases i…

Warsaw, PolandEst. completion Dec 31, 2026

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.